Home/IPOs/SURAKSHA
S

SURAKSHA IPO

Suraksha Diagnostic Limited
Start Date29-11-2024
Application Timing10am-5pm
Price Range₹420 - ₹441
Min Qty34
Min. Investment₹14280
Listing DateNA
Close Date03-12-2024

About Suraksha Diagnostic Limited

Suraksha Diagnostic Limited is the largest full-service and integrated diagnostic chain headquartered in East India. Company offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services to customers through its extensive operational network, consisting of flagship central reference laboratory, 8 satellite laboratories and 194 customer touchpoints which include 48 diagnostic centres, and 146 sample collection centres (franchised), as of March 31, 2024 across the states of West Bengal, Bihar, Assam, and Meghalaya.

Why To Invest in Suraksha Diagnostic Limited

One-stop pathology and radiology testing, and medical consultation services solution provider focused in Eastern region. The Company will not receive any proceeds from the Offer for sale and all proceeds will go to the Selling Shareholders.

Financial Table
Year202420232022
Revenue From Operations (Rs. Cr)218.7190.1223.1
Profit After Tax(Rs. Cr)23.16.0620.8
Strengths And Risks
+
Dominant position in Eastern India: Suraksha Diagnostic is the largest diagnostic chain with a dominant position in Eastern India. With a wide network, it is well positioned to leverage high growth opportunity for organized diagnostic chains in the fragmented diagnostic services markets in Eastern and North-Eastern India.
+
One-stop solution offering : Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services. Compay offers a comprehensive range of 2,300+ tests that cover a range of specialties and disciplines.
+
Developed infrastructure: Company's flagship central reference laboratory in Kolkata is spread over an area of 40,000 square feet, houses a fully automated AI enabled robotic track, liquid chromatography, cytogenetics, and next-gen sequencing capabilities.
+
High brand recall : Company has built a trusted, high quality and reliable brand of choice over the last three decades, evidenced by high repeat rate of over 49%.
-
Geographic concentration: While they have presence across 12 cities and towns in India across the states of West Bengal, Bihar, Assam, and Meghalaya, a significant portion of operations are concentrated in West Bengal. Any loss of market share in the region can impact business.
-
New technologies: Failure to introduce new tests, services and technologies or acquire new or improved equipment could adversely affect business.
-
High competition: With several diagnostic companies present in the market, the diagnostics industry in India is highly competitive and competitors include other well known diagnostic chains, such as, Vijaya Diagnostic Centre Limited, Agilus Diagnostics Limited, Dr. Lal Pathlabs Limited, Metropolis Healthcare Limited and Thyrocare Technologies Limited.
FAQs
What is the Suraksha Diagnostic Limited IPO? +
When will the IPO open? +
What is the lot size of the IPO? +
How to apply for an IPO? +
When will the IPO be allotted? +
When is the IPO listing date? +

Explore Other Products

Rupeezy AppAdvanced charts, advanced Option Chain, instant pay-in & pay-out,margin .Learn More
Rupeezy <> TradingViewEnjoy top-class trading experience enhanced by advanced TradingView charts.Learn More
DockPortfolio analysis, pledge holdings, apply in IPOs & download reports Learn More